PFO
- Product code
- PFO
- Device name
- Active Implantable Bone Conduction Hearing System
- Device class
- Class 2
- 21 CFR
- 21 CFR 874.3340
- Medical specialty
- Ear, Nose, Throat
- Marketing pathway
- 510(K)
- Flag
- Implant
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 12 (all years; only the last 3 years are listed here)
FDA classification definition
An active implantable bone conduction hearing system is a prescription device consisting of an implanted transducer, implanted electronics components, and an audio processor. The active implantable bone conduction hearing system is intended to compensate for conductive or mixed hearing losses by conveying amplified acoustic signals to the cochlea via mechanical vibrations on the skull bone.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K260902 | 2026-07-10 | Cochlear Americas | Cochlear Osia® 3(I) Sound Processor;Cochlear Osia®… | FDA |
| K240614 | 2024-07-10 | Oticon Medical AB | Sentio Ti Implant Kit; Sentio 1 Mini; Genie Medical … | |
| K240155 | 2024-04-18 | Cochlear Americas | Cochlear Osia System |
Official FDA classification page: PFO
Classification and pathway per current FDA publications. Data from openFDA (CC0).